Top News

Sanofi to Divest European Generics Business in Deal Worth $2.4 Billion

April 19, 2018

Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.

Sanofi to Invest Roughly $430 Million in Canadian Vaccine Facility

April 12, 2018

The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.

Roche Completes $1.9-Billion Acquisition of Flatiron Health

April 09, 2018

The acquisition is expected to accelerate progress towards personalized cancer healthcare.

Boehringer Ingelheim and OSE in Immuno-Oncology Deal Worth $1.7 Billion

April 06, 2018

Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.

Fujifilm Expands Bioprocessing Scope

April 05, 2018

Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.

Takeda Confirms Interest in Acquiring Shire

March 28, 2018

Takeda is considering approaching Shire with a possible offer.

GSK Buys Out Novartis’ Share of OTC Business

March 27, 2018

In a $13-billion transaction, GSK will purchase Novartis’ share of the Consumer Healthcare Joint Venture.

Merck & Co., Eisai in Oncology Pact Worth Up to $5.76 Billion

March 19, 2018

The companies intend to jointly develop and commercialize Lenvima (lenvatinib mesylate) as a monotherapy and an in-combination therapy for treating multiple cancer types.

Sanofi Acquires Biogen's Bioverativ

March 13, 2018

The $11.6-billion acquisition strengthens Sanofi's position in hematology and specialty medicines.

Pfizer CentreOne Releases First Green-Chemistry-Driven API

March 08, 2018

The new progesterone active pharmaceutical ingredient, used captively by Pfizer for the past four years, reduces carbon footprint by more than 70%